Clinical trial
Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT…
NCT00327132 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00327132 |
|---|---|
| Title | Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome |
| Official title | Multicentre,Prospective Study of First-line Antibiotic Therapy for Early-stage Low-grade and High-grade Gastric Mucosa-associated Lymphoid Tissue-type Lymphoma and Potential Predicting Factor for Treatment Outcome |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | National Taiwan University Hospital Tri-Service General Hospital Chang Gung Memorial Hospital China Medical University Hospital Changhua Christian Hospital Chi Mei Medical Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Gastric MALT Lymphoma |
| Intervention type | Drug |
| Interventions | Omeprazole, Amoxicillin, Clarithromycin |
| Enrollment | 47 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | May 18, 2006 |
| Last update posted | Mar 25, 2016 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: